Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021 AnnouncementCarolyn MillerNovember 10, 2021Vaxxas, Paul Kelly
Blade Therapeutics Initiates Additional Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis Media ReleaseCarolyn MillerOctober 19, 2021Blade Therapeutics, Paul Kelly
Blade Therapeutics Announces FDA Orphan Drug Designation Granted to Cudetaxestat for Treatment of Systemic Sclerosis Media ReleaseCarolyn MillerOctober 14, 2021Blade Therapeutics, Paul Kelly
Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease Media ReleaseCarolyn MillerOctober 8, 2021Blade Therapeutics, Paul Kelly
Permanent Artificial Hearts Are Closer Than You Think BloombergCarolyn MillerJuly 24, 2021BiVACOR, Paul Kelly
QLD govt commits $20m to vaccine manufacturer InnovationAusCarolyn MillerJune 9, 2021Vaxxas, Paul Kelly
Preclinical studies from Vaxxas and Collaborators Reveal Potential of Vaxxas’ Novel High-Density Microarray Patch (HD-MAP) to Effectively Deliver SARS-CoV-2 Spike Vaccine Media ReleaseCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
Covid-19 vaccine could soon be needle-free The AustralianCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
No need for needle as COVID-19 vaccination patch shows promise Sydney Morning HeraldCarolyn MillerJune 3, 2021Vaxxas, Paul Kelly
Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA® Media ReleaseCarolyn MillerJanuary 12, 2021Clinical Genomics, Paul Kelly
Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer) Media ReleaseCarolyn MillerNovember 16, 2020Clinical Genomics, Paul Kelly
Fresh funds for Qld needle-free vaccine tech start-up Vaxxas AFRCarolyn MillerOctober 6, 2020Vaxxas, Paul Kelly
Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response Media ReleaseCarolyn MillerOctober 6, 2020Paul Kelly, Vaxxas
Could Vaxxas’ tiny patches enable a better COVID-19 vaccine? Drug Delivery BusinessCarolyn MillerSeptember 8, 2020Vaxxas, Paul Kelly
Blade Therapeutics Updates Enrollment Progress for Phase 2 Study of Lead Investigational Therapy BLD-2660 in Treating Patients with COVID-19 Pneumonia Media ReleaseCarolyn MillerAugust 13, 2020Blade Therapeutics, Paul Kelly
Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board Media ReleaseCarolyn MillerAugust 10, 2020Blade Therapeutics, Paul Kelly
KiRA Biotech appoints Global Pharma Business Leader as Independent Board Chair Media ReleaseCarolyn MillerAugust 3, 2020Kira Biotech, Paul Kelly
FDA Approves Xeglyze™ for the topical treatment of head lice infestation Media ReleaseCarolyn MillerAugust 3, 2020Hatchtech, Paul Kelly
